BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Terao R, Kaneko H. Lipid Signaling in Ocular Neovascularization. Int J Mol Sci 2020;21:E4758. [PMID: 32635437 DOI: 10.3390/ijms21134758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shijo T, Sakurada Y, Tanaka K, Miki A, Sugiyama A, Onoe H, Chubachi A, Kikushima W, Wakatsuki Y, Yoneyama S, Mori R, Kashiwagi K. Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment. Sci Rep 2022;12:4715. [PMID: 35304557 DOI: 10.1038/s41598-022-08626-x] [Reference Citation Analysis]
2 Liu S, Gao J, Chen J. Knockdown of lncRNA TUG1 suppresses corneal angiogenesis through regulating miR-505-3p/VEGFA. Microvasc Res 2021;138:104233. [PMID: 34411571 DOI: 10.1016/j.mvr.2021.104233] [Reference Citation Analysis]
3 Lu C, Zhang Q, Zhang H, Li X, Jiang Q, Yao J. A small molecular multi-targeting tyrosine kinase inhibitor, anlotinib, inhibits pathological ocular neovascularization. Biomed Pharmacother 2021;138:111493. [PMID: 33740528 DOI: 10.1016/j.biopha.2021.111493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Suzumura A, Terao R, Kaneko H. Protective Effects and Molecular Signaling of n-3 Fatty Acids on Oxidative Stress and Inflammation in Retinal Diseases.Antioxidants9:920. [PMID: 32993153 DOI: 10.3390/antiox9100920] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]